Obstacles remain for patients with blood cancers

pharmafile | August 20, 2009 | News story | Research and Development, Sales and Marketing NICE, blood cancer 

Related Content

NICE recommends migraine treatment for NHS use

The National Institute for Health and Care Excellence (NICE) has shared draft guidance recommending AbbVie’s …

GSK’s Jemperli recommended by NICE for endometrial cancer treatment

GSK has announced that the National Institute for Health and Care Excellence (NICE) has recommended …

NICE recommends SC treatment of AbbVie’s Tepkinly for patients with DLBCL

AbbVie has announced that the National Institute for Health and Care Excellence (NICE) has recommended …

Latest content